Literature DB >> 21715077

Outcomes of coronary reimplantation for correction of anomalous origin of left coronary artery from pulmonary artery.

Samuel Ramírez1, Pedro J Curi-Curi, Juan Calderón-Colmenero, Jaime García, Cecilia Britton, Julio Erdmenger, Alfonso Buendía, Jorge L Cervantes-Salazar.   

Abstract

INTRODUCTION AND
OBJECTIVES: We report our experience in the surgical correction of anomalous origin of left coronary artery from pulmonary artery (ALCAPA), with an emphasis on the coronary reimplantation technique and its outcome.
METHODS: We designed a retrospective, longitudinal, descriptive study that included patients with ALCAPA who underwent surgery involving coronary reimplantation over a 19-year period. We describe perioperative details such as variations in the surgical technique and the postoperative outcome in terms of morbidity and mortality.
RESULTS: We studied 15 patients (86% females) with a mean age of 6.2 years (range, 2 months to 24 years). Heart failure was the principal cause for hospitalization in 80% of our patients. Left ventricular dysfunction was present in 67%, and 27% had significant or severe mitral valve regurgitation. We describe 3 surgical techniques for coronary reimplantation, the choice of which depends on the site of origin of the anomalous left coronary artery. Four patients underwent an additional mitral valve procedure. The most common immediate postoperative complications were low cardiac output (38%), pleural effusion (17%), and transient ischemia (13%). There was no operative or medium-term mortality.
CONCLUSIONS: Coronary reimplantation is the technique of choice for surgical correction of ALCAPA due to the excellent postoperative survival and low operative morbidity.
Copyright © 2011 Sociedad Española de Cardiología. Published by Elsevier Espana. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21715077     DOI: 10.1016/j.recesp.2011.04.015

Source DB:  PubMed          Journal:  Rev Esp Cardiol        ISSN: 0300-8932            Impact factor:   4.753


  7 in total

1.  Anomalous origin of the left coronary artery from the pulmonary artery in children: diagnostic use of multidetector computed tomography.

Authors:  Quanli Shen; Qiong Yao; Xihong Hu
Journal:  Pediatr Radiol       Date:  2016-05-30

Review 2.  Coronary Artery Development: Progenitor Cells and Differentiation Pathways.

Authors:  Bikram Sharma; Andrew Chang; Kristy Red-Horse
Journal:  Annu Rev Physiol       Date:  2016-12-09       Impact factor: 19.318

3.  Diagnostic Value of Transthoracic Echocardiography in Patients With Anomalous Origin of the Left Coronary Artery From the Pulmonary Artery.

Authors:  Rong-Juan Li; Zhonghua Sun; Jiao Yang; Ya Yang; Yi-Jia Li; Zhao-Ting Leng; Guo-Wen Liu; Li-Hong Pu
Journal:  Medicine (Baltimore)       Date:  2016-04       Impact factor: 1.889

4.  Echocardiographic diagnosis of anomalous origin of the left coronary artery from the pulmonary artery.

Authors:  Xin-Chun Yuan; Jia Hu; Xi Zeng; Ai-Yun Zhou; Li Chen
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

5.  Myocardial performance after coronary re-implantation in pediatric patients assessed with conventional echocardiographic and 2D-speckle tracking analysis: a case-control study.

Authors:  Salma Charfeddine; Dorra Abid; Rania Hammami; Rania Gargouri; Leila Abid; Faten Triki; Samir Kammoun
Journal:  Pan Afr Med J       Date:  2021-01-13

6.  Pre-operative evaluation and mid-term outcomes of anomalous origin of the left coronary artery from the pulmonary artery based on left ventricular ejection fraction.

Authors:  Shu-Liang Xia; Hui-Kang Tao; Li Ma; Yan-Qing Cui; Ming-Hui Zou; Jian-Ru Li; Feng-Xiang Li; Jia Li; Xu Zhang; Xin-Xin Chen
Journal:  Front Cardiovasc Med       Date:  2022-08-09

7.  Diagnosis and treatment of abnormal left coronary artery originating from the pulmonary artery: A single-center experience.

Authors:  Kahraman Yakut; Niyazi Kursad Tokel; Murat Ozkan; Birgul Varan; Ilkay Erdogan; Mehmet Sait Aslamaci
Journal:  Anatol J Cardiol       Date:  2019-11       Impact factor: 1.596

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.